Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prophylactic Application of Donor-derived Central Memory T Lymphocytes (TCM) After Allogeneic HSCT to Prevent Infectious Complications

NCT02758223 is registered in ClinicalTrials.gov with Wuerzburg University Hospital as lead sponsor.

NCT NCT02758223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02758223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prophylactic Application of Donor-derived Central Memory T Lymphocytes (TCM) After Allogeneic HSCT to Prevent Infectious Complications
Lead sponsor
Wuerzburg University Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 2016
Completion date
May 31, 2021
Enrollment
16 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, myeloid, acute, myelodysplastic syndromes